72.98 USD
↘ 3.75 (4.89%)AT CLOSE (03:59 PM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
73.47
↗ 0.48 (0.66%)
POST MARKET (AS OF 05:37 PM EDT)
Post Market
AS OF 05:37 PM EDT
73.47
↗ 0.48 (0.66%)
Market: OPEN
Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $73.47. KNSA shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$76.00
High?$76.48
Low?$70.67
Prev. Close?$76.73
Volume?1.4M
Avg. Volume?603.9K
VWAP?$72.95
Rel. Volume?2.37x
Bid / Ask
Bid?$62.48 × 100
Ask?$84.71 × 100
Spread?$22.23
Midpoint?$73.60
Valuation & Ratios
Market Cap?6.0B
Shares Out?48.3M
Float?39.2M
Float %?81.1%
P/E Ratio?74.22
P/B Ratio?9.15
EPS?$1.03
Dividend?0.40%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?73
Short Sent.?34
Piotroski F-Score?5/9Mixed
Altman Z-Score?16.17Safe
Confidence?60%Moderate
Short InterestHigh
Short % of Float?9.61%Elevated
Short Interest?3.8M
Days to Cover?6.8
Free Float39.2M
Avg Daily Volume555.5K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.90Strong
Quick Ratio?3.49Strong
Cash Ratio?1.03Strong
Debt/Equity?0.13Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score39/100
P/E?74.2PRICEY▾
Peers100
S&P6
P/B?9.15HIGH▾
Peers100
S&P20
P/S?7.12HIGH▾
Peers100
S&P17
P/FCF?32.7FAIR▾
Peers100
S&P25
EV/EBITDA?57.8HIGH▾
Peers100
S&P3
EV/Sales?7.02HIGH▾
Peers100
S&P20
Returns & Efficiency
ROE?12.3%STRONG▾
Peers50
S&P44
ROA?9.0%STRONG▾
Peers50
S&P71
Cash Flow & Enterprise
FCF?$182.8M
Enterprise Value?$5.9B
Fundamentals ratios updated end of day